Experiencia salvadoreña con la interrupción farmacológica del embarazo ectópico [The El Salvadoran experience with medical treatment of ectopic pregnancy]
Gaceta Médica de México 139(suppl 1): S73-S76
Publication date: 2003
Ectopic pregnancy is an important cause of maternal mortality during the first trimester. For some cases of ectopic pregnancy, pharmacologic treatment with methotrexate represents an alternative to surgical procedures. In this report, we present the results of treatment with methotrexate in 25 women with ectopic pregnancies treated at a hospital in San Salvador, El Salvador, between February 2001 and March 2002. Before offering this treatment, certain inclusion and intervention criteria were defined. A follow-up hysterosalpingography was performed in all women to evaluate the condition of fallopian tubes. Twenty two patients (88%) who received treatment with methotrexate were considered treatment successes, that is, no surgery was required; at follow-up, 82% of these successful cases were found to have permeable fallopian tubes. Surgical intervention was necessary in only three cases; tubal permeability was found in two of these cases (75%).